When Medicines Harm: A Systems Analysis of the 2022 Paediatric Acute Kidney Injury Epidemic in The Gambia

Disproportionality and Case-Based Evidence for a Possible Association Between Fluoroquinolones and Kounis Syndrome

Pharmacovigilance signal detection of central nervous system demyelinating diseases following human papillomavirus vaccination: data mining and signal analysis based on the VAERS database

Paroxysmal Nocturnal Hemoglobinuria and Vaccination: A Systematic Pharmacovigilance Analysis of 147 Cases

A real-world pharmacovigilance analysis of cardiac, endocrine, and neurological adverse events associated with cabergoline: a disproportionality study

Integrating pharmacovigilance into quality and regulatory decision making: A systematic review

INTELIGENCIA ARTIFICIAL Y MEDICINA: DIEZ LECCIONES APRENDIDAS (Y OLVIDADAS): 1970-2026

Pharmacovigilance in Ayurveda: Ensuring Safe Use of Traditional Medicines

Prescription safety in elderly cardiology patients: a cross-sectional study

Optimizing cardiac patients safety: Assessing QT interval-prolonging drug alert in electronic prescription in hospitalized patients

Alerta de circulación irregular de fármacos para uso animal

Strengthening Global Drug and Vaccine Safety Through AI-Driven Pharmacovigilance: Myocarditis Signals, mRNA Vaccine AEFIs, and PV Infrastructure Assessment

Aligned MHRA-NICE approval pathway benefits industry over patients

How Advanced Technology Is Reshaping Medication Safety and Pharmacy Practice

Integrating Vadadustat into Pharmaceutical Care for CKD-Related Anemia: Evidence-Based and Pharmacovigilance Perspectives

Dasatinib-Associated Chylothorax: A Scoping Review and Pharmacovigilance Analysis

Drug Recall Systems in Pharmaceutical Regulation: Regulatory Frameworks, Procedures, and Global Perspectives

Connecticut AG’s crackdown leads to major platform halting sales of “research grade” weight loss chemicals to U.S.

Boletín sobre Seguridad de Medicamentos de Uso Humano. Marzo de 2026

ANMAT cancela la autorización de medicamentos con hidroxietil almidón (HEA) y poli(O-2-hydroxietil)-almidón (HEA) para infusión

Proactive drug safety surveillance should be at the heart of the new Health Data Research Service

Prenatal Azithromycin Exposure and Risk of Neurodevelopmental Disorders in Children

Race, Ethnicity, and Language Disparities in Alcohol and Drug Screening and Medication Treatment

Commission welcomes political agreement on Critical Medicines Act

AI-Based Automation for Medication Reconciliation: Scoping Review

The First AI Drug Prescriber

The Burden of Inappropriate Polypharmacy: Approaches to Improve Medication Safety

Factors influencing identification capability of adverse drug reactions in children aged 8–18 years based on social cognitive theory

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

Details of oral anticancer drug prescription audits by community pharmacists: a retrospective analysis of prescription inquiries

Branding en “contextos sensibles”: la seguridad en el packaging farmacéutico en personas mayores a través del análisis de la isoapariencia visual y verbal

Counterfeit Chronicles: Describing and Explicating Online Advertising for Counterfeit Products

BERT-Based Models for Normalization of Adverse Drug Event Expressions in Social Media to Standard Medical Terminology for Drug Safety Analysis

Personalized Dosage System as a Tool for Detecting Adverse Drug Reactions: Pharmaceutical Intervention in a Polymedicated Patient

The EUROmediCAT Network and Databases: A Resource for Pharmacovigilance in Pregnancy

Disproportionality Analysis and Timing of Drug-Associated Guillain–Barré Syndrome Onset Based on the Japanese Adverse Drug Event Report Database

The Role of Electronic Medical Record Systems and Pharmacovigilance Databases in the Surveillance of Antimicrobial Use and Resistance in Low- and Middle-Income Countries: Protocol for a Multistudy Project

Pharmacovigilance analysis and real-world adverse event profile (safety signals and product-related issues) of potassium citrate: a US FDA adverse event reporting system (FAERS) based analysis

Interstitial lung disease associated with novel anticancer agents in non-small cell lung cancer: a pharmacovigilance analysis using the FAERS database

Pharmacovigilance Regulatory Requirements for the Natural Health Products (NHPs) Industry in World Health Organization-Defined High Health Expenditure Countries (2020): A Scoping Review